Cargando…

Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia

BACKGROUND: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. METHODS: This Retrospective, multicenter exploratory-validation analys...

Descripción completa

Detalles Bibliográficos
Autores principales: Gratwohl, Alois, Duarte, Rafael, Snowden, John A., van Biezen, Anja, Baldomero, Helen, Apperley, Jane, Cornelissen, Jan, Greinix, Hildegard T., Grath, Eoin Mc, Mohty, Mohamad, Kroeger, Nicolaus, Nagler, Arnon, Niederwieser, Dietger, Putter, Hein, Brand, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833359/
https://www.ncbi.nlm.nih.gov/pubmed/31709412
http://dx.doi.org/10.1016/j.eclinm.2019.07.019
_version_ 1783466367856410624
author Gratwohl, Alois
Duarte, Rafael
Snowden, John A.
van Biezen, Anja
Baldomero, Helen
Apperley, Jane
Cornelissen, Jan
Greinix, Hildegard T.
Grath, Eoin Mc
Mohty, Mohamad
Kroeger, Nicolaus
Nagler, Arnon
Niederwieser, Dietger
Putter, Hein
Brand, Ronald
author_facet Gratwohl, Alois
Duarte, Rafael
Snowden, John A.
van Biezen, Anja
Baldomero, Helen
Apperley, Jane
Cornelissen, Jan
Greinix, Hildegard T.
Grath, Eoin Mc
Mohty, Mohamad
Kroeger, Nicolaus
Nagler, Arnon
Niederwieser, Dietger
Putter, Hein
Brand, Ronald
author_sort Gratwohl, Alois
collection PubMed
description BACKGROUND: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. METHODS: This Retrospective, multicenter exploratory-validation analysis of 9103 patients, (55.5% male, median age 50 years; 1–75 years range) with an allogeneic HSCT between 2010 and 2016 from a matched sibling (N = 8641; 95%) or matched unrelated donor (N = 462; 5%) for acute myeloid (N = 6432; 71%) or acute lymphoblastic (N = 2671; 29%) leukaemia in first complete remission, and reported by 240 centres in 30 countries to the benchmark database of the European Society for Blood and Marrow Transplantation (EBMT) searched for factors associated with use of transplant techniques (standard N = 6375;70% or reduced intensity conditioning N = 2728;30%, respectively bone marrow N = 1945;21% or peripheral blood N = 7158;79% as stem cell source), and their impact on outcome. FINDINGS: Treatment groups differed significantly from baseline population (p < 0.001), and within groups regarding patient-, disease-, donor-, and centre-related pre-transplantation risk factors (p < 0.001); choice of technique did depend on pre-transplantation risk factors and centre (p < 0.001). Probability of overall survival at 5 years decreased systematically and significantly with increasing pre-transplantation risk score (score 2 vs 0/1 HR: 1·2, 95% c.i. [1·1–1·.3], p = 0.002; score 3 vs 0/1 HR: 1·5, 95% c.i. [1·3–1·7], p < 0.001; score 4/5/6 vs 0/1 HR: 1·9, 95% c.i. [1·6–2·2], p < 0.001) with no significant differences between treatment groups (likelihood ratio test on interaction: p = 0.40). Overall survival was significantly associated with selection steps and completeness of information (p < 0.001). INTERPRETATION: Patients' pre-transplantation risk factors determine survival, independent of transplant techniques. Transplant techniques should be regarded as centre policy, not stratification factor in benchmarking. Selection criteria and completeness of data bias outcome. Outcomes may be improved more effectively through better identifying pre-transplantation factors as opposed to refinement of transplant techniques. FUNDING: The study was funded by EBMT.
format Online
Article
Text
id pubmed-6833359
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68333592019-11-08 Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia Gratwohl, Alois Duarte, Rafael Snowden, John A. van Biezen, Anja Baldomero, Helen Apperley, Jane Cornelissen, Jan Greinix, Hildegard T. Grath, Eoin Mc Mohty, Mohamad Kroeger, Nicolaus Nagler, Arnon Niederwieser, Dietger Putter, Hein Brand, Ronald EClinicalMedicine Research Paper BACKGROUND: The role of conditioning intensity and stem cell source on modifying pre-transplantation risk in allogeneic haematopoietic stem cell transplantation (HSCT) is a matter of debate, but crucial when benchmarking centres. METHODS: This Retrospective, multicenter exploratory-validation analysis of 9103 patients, (55.5% male, median age 50 years; 1–75 years range) with an allogeneic HSCT between 2010 and 2016 from a matched sibling (N = 8641; 95%) or matched unrelated donor (N = 462; 5%) for acute myeloid (N = 6432; 71%) or acute lymphoblastic (N = 2671; 29%) leukaemia in first complete remission, and reported by 240 centres in 30 countries to the benchmark database of the European Society for Blood and Marrow Transplantation (EBMT) searched for factors associated with use of transplant techniques (standard N = 6375;70% or reduced intensity conditioning N = 2728;30%, respectively bone marrow N = 1945;21% or peripheral blood N = 7158;79% as stem cell source), and their impact on outcome. FINDINGS: Treatment groups differed significantly from baseline population (p < 0.001), and within groups regarding patient-, disease-, donor-, and centre-related pre-transplantation risk factors (p < 0.001); choice of technique did depend on pre-transplantation risk factors and centre (p < 0.001). Probability of overall survival at 5 years decreased systematically and significantly with increasing pre-transplantation risk score (score 2 vs 0/1 HR: 1·2, 95% c.i. [1·1–1·.3], p = 0.002; score 3 vs 0/1 HR: 1·5, 95% c.i. [1·3–1·7], p < 0.001; score 4/5/6 vs 0/1 HR: 1·9, 95% c.i. [1·6–2·2], p < 0.001) with no significant differences between treatment groups (likelihood ratio test on interaction: p = 0.40). Overall survival was significantly associated with selection steps and completeness of information (p < 0.001). INTERPRETATION: Patients' pre-transplantation risk factors determine survival, independent of transplant techniques. Transplant techniques should be regarded as centre policy, not stratification factor in benchmarking. Selection criteria and completeness of data bias outcome. Outcomes may be improved more effectively through better identifying pre-transplantation factors as opposed to refinement of transplant techniques. FUNDING: The study was funded by EBMT. Elsevier 2019-08-09 /pmc/articles/PMC6833359/ /pubmed/31709412 http://dx.doi.org/10.1016/j.eclinm.2019.07.019 Text en © 2019 Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Gratwohl, Alois
Duarte, Rafael
Snowden, John A.
van Biezen, Anja
Baldomero, Helen
Apperley, Jane
Cornelissen, Jan
Greinix, Hildegard T.
Grath, Eoin Mc
Mohty, Mohamad
Kroeger, Nicolaus
Nagler, Arnon
Niederwieser, Dietger
Putter, Hein
Brand, Ronald
Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
title Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
title_full Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
title_fullStr Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
title_full_unstemmed Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
title_short Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
title_sort pre-transplantation risks and transplant-techniques in haematopoietic stem cell transplantation for acute leukaemia
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833359/
https://www.ncbi.nlm.nih.gov/pubmed/31709412
http://dx.doi.org/10.1016/j.eclinm.2019.07.019
work_keys_str_mv AT gratwohlalois pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT duarterafael pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT snowdenjohna pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT vanbiezenanja pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT baldomerohelen pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT apperleyjane pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT cornelissenjan pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT greinixhildegardt pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT gratheoinmc pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT mohtymohamad pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT kroegernicolaus pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT naglerarnon pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT niederwieserdietger pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT putterhein pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT brandronald pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia
AT pretransplantationrisksandtransplanttechniquesinhaematopoieticstemcelltransplantationforacuteleukaemia